tirzepatide for 16 year old Mounjaro is second obesity drug to be approved use in England | Obesity More teens are using weight

Nausea and vomitingfrequent early semaglutide side effectslead to electrolyte imbalances that trigger inner-ear sensitivity and spatial disorientation

We may produce less ALDH, meaning acetaldehyde stays in the body for longer

At this stage, many patients continue to see improvements in: Blood sugar control Blood pressure Lipids Inflammation markers which lower cardiovascular risk Mobility and quality of life Focusing only on the scale can miss these meaningful health gains

2024;6:ojae069

GLP-1R agonists delay gastric emptying and reduce food intake in humans to reduce body weight and improve metabolic health for long periods of time (Halawi et al

Clinical data from the SURMOUNT-1 trial showed up to 22.5% body weight reduction at the 15 mg maintenance dose, a figure that exceeded semaglutide trial results by a meaningful margin